MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Non-Invasive 3D Imaging System Enables Physicians to Identify Origin of Arrhythmias Pre-Procedure

By MedImaging International staff writers
Posted on 02 Dec 2022
Print article
Image: VIVO 3D imaging system is designed for pre-procedure arrhythmia localization (Photo courtesy of Catheter Precision)
Image: VIVO 3D imaging system is designed for pre-procedure arrhythmia localization (Photo courtesy of Catheter Precision)

Conventional invasive mapping for identifying the origin of arrhythmias pre-procedure is both time-consuming for localization and often unsuccessful. Now, a novel localization device is setting a new standard for planning of ventricular ablation procedures by enabling physicians to noninvasively identify an area of ventricular arrhythmia onset.

VIVO from Catheter Precision (Mt. Olive, NJ, USA) is a non-invasive 3D imaging system that enables physicians to identify the origin of arrhythmias pre-procedure, streamlining workflow and reducing overall procedure time. VIVO requires acquisition of a MRI or CT image, a standard 12 lead electrocardiogram (ECG) and a 3D photograph of the patient’s torso with the ECG leads in place. These data are used to create patient specific heart and torso models and to identify precise electrode placement of the 12 lead ECG. Once these data are combined, VIVO uses mathematical algorithms to identify the arrhythmia location on a 3D map of the heart, shown in red. The localization, obtained prior to the procedure, can be used in pre-procedure planning.

The VIVO system is comprised of three pieces of equipment and includes hardware (one time purchase) and a single use disposable component. The VIVO software comes loaded on a laptop PC and includes the 3D camera and required accessories, such as a USB cable. Positioning patches are placed on the patient’s torso to aid in positioning the camera for optimal 3D photograph outcomes. So far, the VIVO system has been used in more than 800 procedures in leading U.S. and European hospitals.

“We are always looking to the next milestone in clinical usage of our VIVO System and reaching 800 procedures by the end of 2022 was a goal we set earlier this year,” said David Jenkins, Catheter Precision CEO. “We are gratified by physician adoption so far through our strategic limited launch and look forward to expanding usage in 2023 by growing our sales and clinical support teams to access additional hospitals in new and existing territories.”

Related Links:
Catheter Precision

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
P20 Elite
Ultrasound System
Acclarix AX9
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more